Construction and Validation of a Reliable Disulfidptosis-Related LncRNAs Signature of the Subtype, Prognostic, and Immune Landscape in Colon Cancer
暂无分享,去创建一个
[1] Haibo Wang,et al. Disulfidptosis classification of hepatocellular carcinoma reveals correlation with clinical prognosis and immune profile. , 2023, International immunopharmacology.
[2] J. Thaler,et al. Ongoing complete response after treatment cessation with dabrafenib, trametinib, and cetuximab as third-line treatment in a patient with advanced BRAFV600E mutated, microsatellite-stable colon cancer: A case report and literature review , 2023, Frontiers in Oncology.
[3] Chunting Zhou,et al. Disulfidptosis: a new target for metabolic cancer therapy , 2023, Journal of Experimental & Clinical Cancer Research.
[4] Xi-shan Wang,et al. Pan-cancer analysis identifies PD-L2 as a tumor promotor in the tumor microenvironment , 2023, Frontiers in Immunology.
[5] Rui Chen,et al. Integrated analysis identifies oxidative stress-related lncRNAs associated with progression and prognosis in colorectal cancer , 2023, BMC Bioinformatics.
[6] D. Speiser,et al. CD4+ T cells in cancer , 2023, Nature Cancer.
[7] Feng Zhang,et al. ATP2B1-AS1 exacerbates sepsis-induced cell apoptosis and inflammation by regulating miR-23a-3p/TLR4 axis. , 2023, Allergologia et immunopathologia.
[8] Kellen L. Olszewski,et al. Actin cytoskeleton vulnerability to disulfide stress mediates disulfidptosis , 2023, Nature Cell Biology.
[9] F. Gao,et al. A novel pyroptosis gene expression-based risk score for survival in gastric cancer , 2023, Frontiers in Endocrinology.
[10] Junxin Wu,et al. Role of a lipid metabolism-related lncRNA signature in risk stratification and immune microenvironment for colon cancer , 2022, BMC Medical Genomics.
[11] Shannon M. Mumenthaler,et al. Neurotransmitter signaling: a new frontier in colorectal cancer biology and treatment , 2022, Oncogene.
[12] Junyun Luo,et al. Integrated Analysis of a Ferroptosis-Related LncRNA Signature for Evaluating the Prognosis of Patients with Colorectal Cancer , 2022, Genes.
[13] M. Ryten,et al. ggtranscript: an R package for the visualization and interpretation of transcript isoforms using ggplot2 , 2022, bioRxiv.
[14] R. Samant,et al. Ribosome Biogenesis: A Central Player in Cancer Metastasis and Therapeutic Resistance , 2022, Cancer research.
[15] L. Antonuzzo,et al. Temozolomide Followed by Combination With Low-Dose Ipilimumab and Nivolumab in Patients With Microsatellite-Stable, O6-Methylguanine–DNA Methyltransferase–Silenced Metastatic Colorectal Cancer: The MAYA Trial , 2022, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[16] Chen Chen,et al. Colon cancer diagnosis and staging classification based on machine learning and bioinformatics analysis , 2022, Comput. Biol. Medicine.
[17] Gagandeep Singh,et al. Machine learning assisted analysis of breast cancer gene expression profiles reveals novel potential prognostic biomarkers for triple-negative breast cancer , 2022, Computational and structural biotechnology journal.
[18] S. Shamdani,et al. Weighted correlation network analysis revealed novel long non-coding RNAs for colorectal cancer , 2022, Scientific Reports.
[19] Shengli Liu,et al. Molecular Characteristics, Clinical Significance, and Cancer Immune Interactions of Angiogenesis-Associated Genes in Gastric Cancer , 2022, Frontiers in Immunology.
[20] Y. Zhang,et al. Identification and Validation of Ferroptosis-Related LncRNA Signatures as a Novel Prognostic Model for Colon Cancer , 2022, Frontiers in Immunology.
[21] C. Dang,et al. Targeting cancer metabolism in the era of precision oncology , 2021, Nature reviews. Drug discovery.
[22] Hossein Tabatabaeian,et al. ESRG, LINC00518 and PWRN1 are newly-identified deregulated lncRNAs in colorectal cancer , 2021, Experimental and Molecular Pathology.
[23] Xinxiang Li,et al. Lnc-RP11-536 K7.3/SOX2/HIF-1α signaling axis regulates oxaliplatin resistance in patient-derived colorectal cancer organoids , 2021, Journal of experimental & clinical cancer research : CR.
[24] Linhui Wang,et al. Identification of a Prognosis-Related Risk Signature for Bladder Cancer to Predict Survival and Immune Landscapes , 2021, Journal of immunology research.
[25] Lei Wang,et al. ATP2B1-AS1 Promotes Cerebral Ischemia/Reperfusion Injury Through Regulating the miR-330-5p/TLR4-MyD88-NF-κB Signaling Pathway , 2021, Frontiers in Cell and Developmental Biology.
[26] Robert F. Gruener,et al. oncoPredict: an R package for predicting in vivo or cancer patient drug response and biomarkers from cell line screening data , 2021, Briefings Bioinform..
[27] Xiaochen Bo,et al. clusterProfiler 4.0: A universal enrichment tool for interpreting omics data , 2021, Innovation.
[28] Yue Zhou,et al. Insight into Crosstalk between Ferroptosis and Necroptosis: Novel Therapeutics in Ischemic Stroke , 2021, Oxidative medicine and cellular longevity.
[29] C. Rudin,et al. Tim-4+ cavity-resident macrophages impair anti-tumor CD8+ T cell immunity. , 2021, Cancer cell.
[30] X. Zu,et al. YTHDF1 Is a Potential Pan-Cancer Biomarker for Prognosis and Immunotherapy , 2021, Frontiers in Oncology.
[31] Senlin Xu,et al. Alternative approaches to target Myc for cancer treatment , 2021, Signal Transduction and Targeted Therapy.
[32] Xian Shen,et al. Long noncoding RNAs: functions and mechanisms in colon cancer , 2020, Molecular Cancer.
[33] L. Zhuang,et al. Cystine transporter SLC7A11/xCT in cancer: ferroptosis, nutrient dependency, and cancer therapy , 2020, Protein & Cell.
[34] L. Zitvogel,et al. Immunostimulation with chemotherapy in the era of immune checkpoint inhibitors , 2020, Nature Reviews Clinical Oncology.
[35] Kaiyou Song,et al. Silencing of ATP2B1‐AS1 contributes to protection against myocardial infarction in mouse via blocking NFKBIA‐mediated NF‐κB signalling pathway , 2020, Journal of cellular and molecular medicine.
[36] Xipeng Zhang,et al. A Robust 6-lncRNA Prognostic Signature for Predicting the Prognosis of Patients With Colorectal Cancer Metastasis , 2020, Frontiers in Medicine.
[37] A. G. García Carrancá,et al. mTORC1 as a Regulator of Mitochondrial Functions and a Therapeutic Target in Cancer , 2019, Front. Oncol..
[38] Enxin Zhang,et al. Integrated analysis of lncRNA-miRNA-mRNA ceRNA network in squamous cell carcinoma of tongue , 2019, BMC Cancer.
[39] Z. Trajanoski,et al. Correction to: Molecular and pharmacological modulators of the tumor immune contexture revealed by deconvolution of RNA-seq data , 2019, Genome Medicine.
[40] J. Ross,et al. Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer. , 2019, Annals of oncology : official journal of the European Society for Medical Oncology.
[41] G. Leone,et al. The broken cycle: E2F dysfunction in cancer , 2019, Nature Reviews Cancer.
[42] Yassen Assenov,et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer , 2018, Genome research.
[43] M. Leach,et al. Metabolic biomarkers of response to the AKT inhibitor MK-2206 in pre-clinical models of human colorectal and prostate carcinoma , 2018, British Journal of Cancer.
[44] X. Liu,et al. Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response , 2018, Nature Medicine.
[45] Timothy Solberg,et al. Machine learning algorithms for outcome prediction in (chemo)radiotherapy: An empirical comparison of classifiers , 2018, Medical physics.
[46] D. Sansom,et al. CTLA-4: a moving target in immunotherapy. , 2018, Blood.
[47] Jun S. Liu,et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. , 2017, Cancer research.
[48] Guang-Rong Yan,et al. A Peptide Encoded by a Putative lncRNA HOXB-AS3 Suppresses Colon Cancer Growth. , 2017, Molecular cell.
[49] Noam Shental,et al. Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine , 2017, Science.
[50] A. Butte,et al. xCell: digitally portraying the tissue cellular heterogeneity landscape , 2017, bioRxiv.
[51] A. Ratti,et al. The Long Non-Coding RNAs in Neurodegenerative Diseases: Novel Mechanisms of Pathogenesis. , 2016, Current Alzheimer research.
[52] Jeffrey S. Morris,et al. The Consensus Molecular Subtypes of Colorectal Cancer , 2015, Nature Medicine.
[53] Ron Bose,et al. HER2 activating mutations are targets for colorectal cancer treatment. , 2015, Cancer discovery.
[54] R. Emerson,et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance , 2014, Nature.
[55] K Ito,et al. Application of ggplot2 to Pharmacometric Graphics , 2013, CPT: pharmacometrics & systems pharmacology.
[56] Justin Guinney,et al. GSVA: gene set variation analysis for microarray and RNA-Seq data , 2013, BMC Bioinformatics.
[57] Sridhar Ramaswamy,et al. Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells , 2012, Nucleic Acids Res..
[58] P. Reichardt,et al. Human Regulatory T Cells Rapidly Suppress T Cell Receptor–Induced Ca2+, NF-κB, and NFAT Signaling in Conventional T Cells , 2011, Science Signaling.
[59] W. El-Deiry,et al. Off-Target Lapatinib Activity Sensitizes Colon Cancer Cells Through TRAIL Death Receptor Up-Regulation , 2011, Science Translational Medicine.
[60] Davis J. McCarthy,et al. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data , 2009, Bioinform..
[61] M. Cappell,et al. Pathophysiology, clinical presentation, and management of colon cancer. , 2008, Gastroenterology clinics of North America.
[62] Guido Kroemer,et al. Self-eating and self-killing: crosstalk between autophagy and apoptosis , 2007, Nature Reviews Molecular Cell Biology.
[63] Z. Trajanoski,et al. Type, Density, and Location of Immune Cells Within Human Colorectal Tumors Predict Clinical Outcome , 2006, Science.
[64] M. Guha,et al. Mitochondria-to-nucleus stress signaling in mammalian cells: nature of nuclear gene targets, transcription regulation, and induced resistance to apoptosis. , 2005, Gene.
[65] T. Hickish,et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. , 2004, The New England journal of medicine.
[66] Ash A. Alizadeh,et al. SUPPLEMENTARY NOTE , 1879, Botanical Gazette.
[67] I. Endo,et al. G2M checkpoint pathway alone is associated with drug response and survival among cell proliferation-related pathways in pancreatic cancer. , 2021, American journal of cancer research.
[68] D. Gfeller,et al. EPIC: A Tool to Estimate the Proportions of Different Cell Types from Bulk Gene Expression Data. , 2020, Methods in molecular biology.
[69] Jacob D. Jaffe,et al. Next-generation characterization of the Cancer Cell Line Encyclopedia , 2019, Nature.